Literature DB >> 29764988

You've made the diagnosis of functional neurological disorder: now what?

Caitlin Adams1,2, Jordan Anderson3,4, Elizabeth N Madva1,2, W Curt LaFrance3,4, David L Perez1,2.   

Abstract

Patients with functional neurological disorders (FND)/conversion disorder commonly present to outpatient clinics. FND is now a 'rule in' diagnosis based on neurological examination findings and semiological features. While neurologists may be more comfortable diagnosing patients with FND, there is only limited guidance as to how to conduct follow-up outpatient visits. Using clinical vignettes, we provide practical suggestions that may help guide clinical encounters including how to: (1) explore illness beliefs openly; (2) enquire longitudinally about predisposing vulnerabilities, acute precipitants and perpetuating factors that may be further elucidated over time; (3) facilitate psychotherapy engagement by actively listening for potentially unhelpful or maladaptive patterns of thoughts, behaviours, fears or psychosocial stressors that can be reflected back to the patient and (4) enquire about the fidelity of individual treatments and educate other providers who may be less familiar with FND. These suggestions, while important to individualise, provide a blueprint for follow-up FND clinical care. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  conversion disorder; functional movement disorders; neuropsychiatry; psychogenic nonepileptic seizures

Mesh:

Year:  2018        PMID: 29764988      PMCID: PMC6372294          DOI: 10.1136/practneurol-2017-001835

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  22 in total

1.  The bare essentials: Functional symptoms in neurology.

Authors:  Jon Stone
Journal:  Pract Neurol       Date:  2009-06

2.  Illness beliefs and locus of control: a comparison of patients with pseudoseizures and epilepsy.

Authors:  Jon Stone; Michael Binzer; Michael Sharpe
Journal:  J Psychosom Res       Date:  2004-12       Impact factor: 3.006

3.  Causal illness attributions in somatoform disorders: associations with comorbidity and illness behavior.

Authors:  Winfried Rief; Alexandra Nanke; Julia Emmerich; Andrea Bender; Thomas Zech
Journal:  J Psychosom Res       Date:  2004-10       Impact factor: 3.006

4.  Treatment of nonepileptic seizures.

Authors:  W Curt LaFrance; Orrin Devinsky
Journal:  Epilepsy Behav       Date:  2002-10       Impact factor: 2.937

5.  "Wheelchair" patients with nonorganic disease: a psychological inquiry.

Authors:  P Davison; M Sharpe; D Wade; C Bass
Journal:  J Psychosom Res       Date:  1999-07       Impact factor: 3.006

6.  Non-epileptic seizures and other functional neurological symptoms: predisposing, precipitating, and perpetuating factors.

Authors:  Markus Reuber; Stephanie Howlett; Ajjaz Khan; Richard A Grünewald
Journal:  Psychosomatics       Date:  2007 May-Jun       Impact factor: 2.386

7.  Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures.

Authors:  Lindsey Hall-Patch; Richard Brown; Allan House; Stephanie Howlett; Steven Kemp; Gemma Lawton; Rebecca Mayor; Phil Smith; Markus Reuber
Journal:  Epilepsia       Date:  2009-04-27       Impact factor: 5.864

Review 8.  The etiology of psychogenic non-epileptic seizures: toward a biopsychosocial model.

Authors:  Markus Reuber
Journal:  Neurol Clin       Date:  2009-11       Impact factor: 3.806

9.  Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?

Authors:  Jon Stone; A Carson; R Duncan; R Coleman; R Roberts; C Warlow; C Hibberd; G Murray; R Cull; A Pelosi; J Cavanagh; K Matthews; R Goldbeck; R Smyth; J Walker; A D Macmahon; M Sharpe
Journal:  Brain       Date:  2009-09-08       Impact factor: 13.501

Review 10.  In the psychiatrist's chair: how neurologists understand conversion disorder.

Authors:  Richard Kanaan; David Armstrong; Philip Barnes; Simon Wessely
Journal:  Brain       Date:  2009-03-24       Impact factor: 13.501

View more
  7 in total

1.  [Functional neurological disorders: update and example of integrated inpatient treatment including mirror therapy].

Authors:  A Joos; R Halmer; N Leiprecht; K Schörner; C Lahmann; C Blahak
Journal:  Nervenarzt       Date:  2020-03       Impact factor: 1.214

2.  Psychiatrists' Understanding and Management of Conversion Disorder: A Bi-National Survey and Comparison with Neurologists.

Authors:  Benjamin Dent; Biba R Stanton; Richard A Kanaan
Journal:  Neuropsychiatr Dis Treat       Date:  2020-08-12       Impact factor: 2.570

3.  When neurologists diagnose functional neurological disorder, why don't they code for it?

Authors:  Lorena DoVal Herbert; Rachel Kim; Asim Ao Hassan; Alison Wilkinson-Smith; Jeff L Waugh
Journal:  CNS Spectr       Date:  2021-09-15       Impact factor: 3.790

4.  Functional neurological disorders: effective teaching for health professionals.

Authors:  Alexander Lehn; Dharsha Navaratnam; Megan Broughton; Vince Cheah; Alison Fenton; Karl Harm; Diana Owen; Paul Pun
Journal:  BMJ Neurol Open       Date:  2020-06-28

Review 5.  Functional movement disorder and functional seizures: What have we learned from different subtypes of functional neurological disorders?

Authors:  Sushma Kola; Kathrin LaFaver
Journal:  Epilepsy Behav Rep       Date:  2021-11-26

6.  Twisted in Pain: The Multidisciplinary Treatment Approach to Functional Dystonia.

Authors:  Yogesh Khachane; Kasia Kozlowska; Blanche Savage; Georgia McClure; Gretel Butler; Nicola Gray; Andrea Worth; Samantha Mihailovich; David L Perez; Helene Helgeland; George P Chrousos
Journal:  Harv Rev Psychiatry       Date:  2019 Nov/Dec       Impact factor: 3.732

7.  Economic Costs of Delayed Diagnosis of Functional Motor Disorders: Preliminary Results From a Cohort of Patients of a Specialized Clinic.

Authors:  Michele Tinazzi; Marialuisa Gandolfi; Stefano Landi; Chiara Leardini
Journal:  Front Neurol       Date:  2021-12-08       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.